SH PHARMACEU -H-
SH PHARMACEU -H- operates in Diversified Metals & Mining.
SH PHARMACEU -H- (S1R) - Total Assets
Latest total assets as of September 2024: €223.74 Billion EUR
Based on the latest financial reports, SH PHARMACEU -H- (S1R) holds total assets worth €223.74 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SH PHARMACEU -H- - Total Assets Trend (2016–2023)
This chart illustrates how SH PHARMACEU -H-’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SH PHARMACEU -H- - Asset Composition Analysis
Current Asset Composition (December 2023)
SH PHARMACEU -H-'s total assets of €223.74 Billion consist of 76.6% current assets and 23.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.4% |
| Accounts Receivable | €72.93 Billion | 34.4% |
| Inventory | €36.62 Billion | 17.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.36 Billion | 3.0% |
| Goodwill | €11.39 Billion | 5.4% |
Asset Composition Trend (2016–2023)
This chart illustrates how SH PHARMACEU -H-'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SH PHARMACEU -H-'s current assets represent 76.6% of total assets in 2023, an increase from 72.8% in 2016.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2023, down from 14.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 10.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 34.4% of total assets.
SH PHARMACEU -H- Competitors by Total Assets
Key competitors of SH PHARMACEU -H- based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
SH PHARMACEU -H- - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - SH PHARMACEU -H- generates 1.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, SH PHARMACEU -H- generates $ 1.78 in net profit.
SH PHARMACEU -H- - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.34 | 1.34 | 1.31 |
| Quick Ratio | 1.05 | 1.06 | 0.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €44.26 Billion | € 42.20 Billion | € 23.48 Billion |
SH PHARMACEU -H- - Advanced Valuation Insights
This section examines the relationship between SH PHARMACEU -H-'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.0% |
| Total Assets | €211.97 Billion |
| Market Capitalization | $11.30K USD |
Valuation Analysis
Below Book Valuation: The market values SH PHARMACEU -H-'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: SH PHARMACEU -H-'s assets grew by 7.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for SH PHARMACEU -H- (2016–2023)
The table below shows the annual total assets of SH PHARMACEU -H- from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €211.97 Billion | +6.98% |
| 2022-12-31 | €198.13 Billion | +21.23% |
| 2021-12-31 | €163.44 Billion | +9.55% |
| 2020-12-31 | €149.19 Billion | +8.87% |
| 2019-12-31 | €137.03 Billion | +8.00% |
| 2018-12-31 | €126.88 Billion | +34.49% |
| 2017-12-31 | €94.34 Billion | +14.02% |
| 2016-12-31 | €82.74 Billion | -- |